1. Home
  2. SWMR vs RGNX Comparison

SWMR vs RGNX Comparison

Compare SWMR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SWMR

Swarmer Inc Common Stock

N/A

Current Price

$37.09

Market Cap

453.1M

Sector

Technology

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.79

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWMR
RGNX
Founded
2023
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
453.1M
528.6M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
SWMR
RGNX
Price
$37.09
$9.79
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.75
AVG Volume (30 Days)
257.7K
2.0M
Earning Date
05-20-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$2,862.05
$51.21
Revenue Next Year
$177.93
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$25.75
$5.46
52 Week High
$83.30
$16.19

Technical Indicators

Market Signals
Indicator
SWMR
RGNX
Relative Strength Index (RSI) 43.67 43.91
Support Level $34.42 $9.51
Resistance Level $38.06 $11.00
Average True Range (ATR) 3.50 0.75
MACD -0.18 -0.29
Stochastic Oscillator 24.01 35.53

Price Performance

Historical Comparison
SWMR
RGNX

About SWMR Swarmer Inc Common Stock

Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: